Caliper Eyeing MDx, Sequencing Sample Prep Opportunities | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – Caliper Life Sciences is working on developing its technologies for future uses in molecular diagnostics and front-end sample preparation for next-generation sequencing systems.

Those opportunities are two of three major initiatives in the firm's pipeline, President and CEO Kevin Hrusovsky said Thursday at the JPMorgan Healthcare Conference held here. The company also is working on a new, integrated molecular biology workstation.
But key future revenue drivers could come in the form of the sequencing sample prep and MDx instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.